PERMED
Personalized Medicine 2020 and beyond – Preparing Europe for leading the global way (PerMed)
| Coordinatore | DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV
Organization address
address: Linder Hoehe contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Totale costo | 645˙115 € |
| EC contributo | 497˙378 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2013-INNOVATION-1 |
| Funding Scheme | CSA-SA |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-09-01 - 2015-08-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV
Organization address
address: Linder Hoehe contact info |
DE (KOELN) | coordinator | 187˙506.00 |
| 2 |
INTERNATIONALES FORUM GASTEIN VEREIN
Organization address
address: TAUERNPLATZ 1 contact info |
AT (BAD HOFGASTEIN) | participant | 74˙900.00 |
| 3 |
INSTITUTO DE SALUD CARLOS III
Organization address
address: CALLE SINESIO DELGADO 4-6 contact info |
ES (MADRID) | participant | 40˙125.00 |
| 4 |
MINISTERO DELLA SALUTE
Organization address
address: Via Giorgio Ribotta 5 contact info |
IT (ROMA) | participant | 32˙635.00 |
| 5 |
UNIVERSITEIT MAASTRICHT
Organization address
address: Minderbroedersberg 4-6 contact info |
NL (MAASTRICHT) | participant | 31˙993.00 |
| 6 |
THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT
Organization address
address: Laan Van Nieuw Oost Indie 334 contact info |
NL (DEN HAAG) | participant | 29˙639.00 |
| 7 |
INSTITUT NATIONAL DU CANCER
Organization address
city: Boulogne-Billancourt contact info |
FR (Boulogne-Billancourt) | participant | 29˙425.00 |
| 8 |
ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY
Organization address
address: SHERBROOKE STREET WEST 845 contact info |
CA (MONTREAL) | participant | 19˙260.00 |
| 9 |
MEDICAL RESEARCH COUNCIL
Organization address
address: NORTH STAR AVENUE POLARIS HOUSE contact info |
UK (SWINDON) | participant | 16˙585.00 |
| 10 |
MINISTRY OF HEALTH
Organization address
address: 2 Ben Tabai Street contact info |
IL (JERUSALEM) | participant | 13˙910.00 |
| 11 |
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Organization address
address: RUE LEBLANC 25 contact info |
FR (PARIS 15) | participant | 10˙700.00 |
| 12 |
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE
Organization address
address: KURT GEORG KIESINGER ALLEE 3 contact info |
DE (BONN) | participant | 2˙675.00 |
| 13 |
FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS
Organization address
address: PLAZA ASUA 1 contact info |
ES (SONDIKA) | participant | 2˙675.00 |
| 14 |
HELSINGIN YLIOPISTO
Organization address
address: YLIOPISTONKATU 4 contact info |
FI (HELSINGIN YLIOPISTO) | participant | 2˙675.00 |
| 15 |
SOCIETE EUROPEENNE DE PHARMACOGENOMIQUE ET THERANOSTIQUE - EUROPEAN SOCIETY OF PHARMACOGENOMICS AND THERANOSTICS ASSOCIATION
Organization address
address: RUE LIONNOIS 30 UNIVERSITE DE LORRAINE contact info |
FR (NANCY) | participant | 2˙675.00 |
| 16 |
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG
Organization address
address: Heinemannstrasse 2 contact info |
DE (BONN) | participant | 0.00 |
| 17 |
FONDATION EUROPEENNE DE LA SCIENCE
Organization address
address: QUAI LEZAY MARNESIA 1 contact info |
FR (STRASBOURG CEDEX) | participant | 0.00 |
| 18 |
FONDS NATIONAL DE LA RECHERCHE
Organization address
address: RUE ANTOINE DE SAINT EXUPERY 6 contact info |
LU (LUXEMBOURG) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The Health Directorate of the European Commission's DG Research and Innovation recently stated that Personalized Medicine is one of the most innovative areas in the future of health research with a high potential for patients, citizens and the economy. However, today the full potential can not be developed due to fragmented activities, insufficient communication and lack of generic solutions in the different areas of Personalized Medicine.The implementation of Personalized Medicine is, therefore, a major challenge in Europe and beyond. It calls for appropriate governance strategies at the European and global level as it challenges the way in which healthcare systems worldwide are set up. Thus, the EC itself, EuroBioForum, the European Health Forum Gastein (EHFG) and others have organized conferences to tackle these challenges. Furthermore, key European organizations and institutions have come up with reports, guidelines, roadmaps aiming to give guidance in this emerging and important health research field amongst others the European Science Foundation (ESF) Forward Look, the Manifesto of the European Alliance for Personalised Medicine (EAPM), the European Best Practice Guidelines of the Public Health Genomics European Network (PHGEN), the Roche report on Personalized Medicine or the report of the European Hospital and Healthcare Federation (HOPE). Based on these initiatives European and national decision-makers and funding bodies not only have expressed the urgent need for a CSA, but also initiated this specific CSA to step up coordination efforts between the European key stakeholders to allow synergies and avoid duplication or competition, to ensure maximum transparency and openness preparing Europe for leading the global way.'
Altri progetti dello stesso programma (FP7-HEALTH)
UNICELLSYS (2008)
Eukaryotic unicellular organism biology – systems biology of the control of cell growth and proliferation
Read MoreGENEGRAFT (2011)
Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector
Read More